Growth in this market is driven by the increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries.
The Hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.14 billion in 2017 at a CAGR of 6.0%.
+ Market Dynamics
+ Increasing Number of Surgical Procedures
+ Growing Number of Regulatory Approvals
+ Increasing Incidence of Sports-Related Injuries and Spinal Ailments
+ Rising Focus on Effective Blood Loss Management in Patients During Surgeries
Download PDF Brochure @
“The thrombin-based hemostats segment is expected to account for the largest share of the market in 2018.”
Based on product, the hemostats market is segmented into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. Of all these product segments, the thrombin-based hemostats segment is expected to account for the largest share of the global hemostats market in 2018.
“In 2018, the orthopedic surgery segment is expected to dominate the hemostats market”
On the basis of application, the hemostats market is segmented neurological surgery, cardiovascular surgery, general surgery, orthopedic surgery, gynecological surgery, reconstructive surgery, and other surgeries. The orthopedic surgery segment is expected to account for the largest share of the hemostats market in 2018.
View complete press release:-